0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Outsourcing in Drug Development Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-37L5834
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Outsourcing in Drug Development Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Outsourcing in Drug Development Market Research Report 2025

Code: QYRE-Auto-37L5834
Report
September 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Outsourcing in Drug Development Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Outsourcing in Drug Development Market

Outsourcing in Drug Development Market

The global market for Outsourcing in Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
For a biopharmaceutical industry in flux, outsourcing services are playing a greater and more diverse role in drug development.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Outsourcing in Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Outsourcing in Drug Development.
The Outsourcing in Drug Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Outsourcing in Drug Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Outsourcing in Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Outsourcing in Drug Development Market Report

Report Metric Details
Report Name Outsourcing in Drug Development Market
CAGR 5%
Segment by Type
  • Clinical Trials
  • New Drug Application
Segment by Application
  • Pharmaceutical Industries
  • Biotechnology Industries
  • Medical Device Industries
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River Laboratories, Covance, ICON, Parexel, Quintiles Transnational, PPD, PRA Health Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Outsourcing in Drug Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Outsourcing in Drug Development Market report?

Ans: The main players in the Outsourcing in Drug Development Market are Charles River Laboratories, Covance, ICON, Parexel, Quintiles Transnational, PPD, PRA Health Sciences

What are the Application segmentation covered in the Outsourcing in Drug Development Market report?

Ans: The Applications covered in the Outsourcing in Drug Development Market report are Pharmaceutical Industries, Biotechnology Industries, Medical Device Industries

What are the Type segmentation covered in the Outsourcing in Drug Development Market report?

Ans: The Types covered in the Outsourcing in Drug Development Market report are Clinical Trials, New Drug Application

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Outsourcing in Drug Development Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Clinical Trials
1.2.3 New Drug Application
1.3 Market by Application
1.3.1 Global Outsourcing in Drug Development Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Industries
1.3.3 Biotechnology Industries
1.3.4 Medical Device Industries
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Outsourcing in Drug Development Market Perspective (2020-2031)
2.2 Global Outsourcing in Drug Development Growth Trends by Region
2.2.1 Global Outsourcing in Drug Development Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Outsourcing in Drug Development Historic Market Size by Region (2020-2025)
2.2.3 Outsourcing in Drug Development Forecasted Market Size by Region (2026-2031)
2.3 Outsourcing in Drug Development Market Dynamics
2.3.1 Outsourcing in Drug Development Industry Trends
2.3.2 Outsourcing in Drug Development Market Drivers
2.3.3 Outsourcing in Drug Development Market Challenges
2.3.4 Outsourcing in Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Outsourcing in Drug Development Players by Revenue
3.1.1 Global Top Outsourcing in Drug Development Players by Revenue (2020-2025)
3.1.2 Global Outsourcing in Drug Development Revenue Market Share by Players (2020-2025)
3.2 Global Outsourcing in Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Outsourcing in Drug Development Revenue
3.4 Global Outsourcing in Drug Development Market Concentration Ratio
3.4.1 Global Outsourcing in Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Outsourcing in Drug Development Revenue in 2024
3.5 Global Key Players of Outsourcing in Drug Development Head office and Area Served
3.6 Global Key Players of Outsourcing in Drug Development, Product and Application
3.7 Global Key Players of Outsourcing in Drug Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Outsourcing in Drug Development Breakdown Data by Type
4.1 Global Outsourcing in Drug Development Historic Market Size by Type (2020-2025)
4.2 Global Outsourcing in Drug Development Forecasted Market Size by Type (2026-2031)
5 Outsourcing in Drug Development Breakdown Data by Application
5.1 Global Outsourcing in Drug Development Historic Market Size by Application (2020-2025)
5.2 Global Outsourcing in Drug Development Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Outsourcing in Drug Development Market Size (2020-2031)
6.2 North America Outsourcing in Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Outsourcing in Drug Development Market Size by Country (2020-2025)
6.4 North America Outsourcing in Drug Development Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Outsourcing in Drug Development Market Size (2020-2031)
7.2 Europe Outsourcing in Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Outsourcing in Drug Development Market Size by Country (2020-2025)
7.4 Europe Outsourcing in Drug Development Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Outsourcing in Drug Development Market Size (2020-2031)
8.2 Asia-Pacific Outsourcing in Drug Development Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Outsourcing in Drug Development Market Size by Region (2020-2025)
8.4 Asia-Pacific Outsourcing in Drug Development Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Outsourcing in Drug Development Market Size (2020-2031)
9.2 Latin America Outsourcing in Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Outsourcing in Drug Development Market Size by Country (2020-2025)
9.4 Latin America Outsourcing in Drug Development Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Outsourcing in Drug Development Market Size (2020-2031)
10.2 Middle East & Africa Outsourcing in Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Outsourcing in Drug Development Market Size by Country (2020-2025)
10.4 Middle East & Africa Outsourcing in Drug Development Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Outsourcing in Drug Development Introduction
11.1.4 Charles River Laboratories Revenue in Outsourcing in Drug Development Business (2020-2025)
11.1.5 Charles River Laboratories Recent Development
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance Outsourcing in Drug Development Introduction
11.2.4 Covance Revenue in Outsourcing in Drug Development Business (2020-2025)
11.2.5 Covance Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Outsourcing in Drug Development Introduction
11.3.4 ICON Revenue in Outsourcing in Drug Development Business (2020-2025)
11.3.5 ICON Recent Development
11.4 Parexel
11.4.1 Parexel Company Details
11.4.2 Parexel Business Overview
11.4.3 Parexel Outsourcing in Drug Development Introduction
11.4.4 Parexel Revenue in Outsourcing in Drug Development Business (2020-2025)
11.4.5 Parexel Recent Development
11.5 Quintiles Transnational
11.5.1 Quintiles Transnational Company Details
11.5.2 Quintiles Transnational Business Overview
11.5.3 Quintiles Transnational Outsourcing in Drug Development Introduction
11.5.4 Quintiles Transnational Revenue in Outsourcing in Drug Development Business (2020-2025)
11.5.5 Quintiles Transnational Recent Development
11.6 PPD
11.6.1 PPD Company Details
11.6.2 PPD Business Overview
11.6.3 PPD Outsourcing in Drug Development Introduction
11.6.4 PPD Revenue in Outsourcing in Drug Development Business (2020-2025)
11.6.5 PPD Recent Development
11.7 PRA Health Sciences
11.7.1 PRA Health Sciences Company Details
11.7.2 PRA Health Sciences Business Overview
11.7.3 PRA Health Sciences Outsourcing in Drug Development Introduction
11.7.4 PRA Health Sciences Revenue in Outsourcing in Drug Development Business (2020-2025)
11.7.5 PRA Health Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Outsourcing in Drug Development Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Clinical Trials
 Table 3. Key Players of New Drug Application
 Table 4. Global Outsourcing in Drug Development Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Outsourcing in Drug Development Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Outsourcing in Drug Development Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Outsourcing in Drug Development Market Share by Region (2020-2025)
 Table 8. Global Outsourcing in Drug Development Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Outsourcing in Drug Development Market Share by Region (2026-2031)
 Table 10. Outsourcing in Drug Development Market Trends
 Table 11. Outsourcing in Drug Development Market Drivers
 Table 12. Outsourcing in Drug Development Market Challenges
 Table 13. Outsourcing in Drug Development Market Restraints
 Table 14. Global Outsourcing in Drug Development Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Outsourcing in Drug Development Market Share by Players (2020-2025)
 Table 16. Global Top Outsourcing in Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Outsourcing in Drug Development as of 2024)
 Table 17. Ranking of Global Top Outsourcing in Drug Development Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Outsourcing in Drug Development Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Outsourcing in Drug Development, Headquarters and Area Served
 Table 20. Global Key Players of Outsourcing in Drug Development, Product and Application
 Table 21. Global Key Players of Outsourcing in Drug Development, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Outsourcing in Drug Development Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Outsourcing in Drug Development Revenue Market Share by Type (2020-2025)
 Table 25. Global Outsourcing in Drug Development Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Outsourcing in Drug Development Revenue Market Share by Type (2026-2031)
 Table 27. Global Outsourcing in Drug Development Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Outsourcing in Drug Development Revenue Market Share by Application (2020-2025)
 Table 29. Global Outsourcing in Drug Development Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Outsourcing in Drug Development Revenue Market Share by Application (2026-2031)
 Table 31. North America Outsourcing in Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Outsourcing in Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Outsourcing in Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Outsourcing in Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Outsourcing in Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Outsourcing in Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Outsourcing in Drug Development Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Outsourcing in Drug Development Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Outsourcing in Drug Development Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Outsourcing in Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Outsourcing in Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Outsourcing in Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Outsourcing in Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Outsourcing in Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Outsourcing in Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Charles River Laboratories Company Details
 Table 47. Charles River Laboratories Business Overview
 Table 48. Charles River Laboratories Outsourcing in Drug Development Product
 Table 49. Charles River Laboratories Revenue in Outsourcing in Drug Development Business (2020-2025) & (US$ Million)
 Table 50. Charles River Laboratories Recent Development
 Table 51. Covance Company Details
 Table 52. Covance Business Overview
 Table 53. Covance Outsourcing in Drug Development Product
 Table 54. Covance Revenue in Outsourcing in Drug Development Business (2020-2025) & (US$ Million)
 Table 55. Covance Recent Development
 Table 56. ICON Company Details
 Table 57. ICON Business Overview
 Table 58. ICON Outsourcing in Drug Development Product
 Table 59. ICON Revenue in Outsourcing in Drug Development Business (2020-2025) & (US$ Million)
 Table 60. ICON Recent Development
 Table 61. Parexel Company Details
 Table 62. Parexel Business Overview
 Table 63. Parexel Outsourcing in Drug Development Product
 Table 64. Parexel Revenue in Outsourcing in Drug Development Business (2020-2025) & (US$ Million)
 Table 65. Parexel Recent Development
 Table 66. Quintiles Transnational Company Details
 Table 67. Quintiles Transnational Business Overview
 Table 68. Quintiles Transnational Outsourcing in Drug Development Product
 Table 69. Quintiles Transnational Revenue in Outsourcing in Drug Development Business (2020-2025) & (US$ Million)
 Table 70. Quintiles Transnational Recent Development
 Table 71. PPD Company Details
 Table 72. PPD Business Overview
 Table 73. PPD Outsourcing in Drug Development Product
 Table 74. PPD Revenue in Outsourcing in Drug Development Business (2020-2025) & (US$ Million)
 Table 75. PPD Recent Development
 Table 76. PRA Health Sciences Company Details
 Table 77. PRA Health Sciences Business Overview
 Table 78. PRA Health Sciences Outsourcing in Drug Development Product
 Table 79. PRA Health Sciences Revenue in Outsourcing in Drug Development Business (2020-2025) & (US$ Million)
 Table 80. PRA Health Sciences Recent Development
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources
 Table 84. Authors List of This Report


List of Figures
 Figure 1. Outsourcing in Drug Development Picture
 Figure 2. Global Outsourcing in Drug Development Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Outsourcing in Drug Development Market Share by Type: 2024 VS 2031
 Figure 4. Clinical Trials Features
 Figure 5. New Drug Application Features
 Figure 6. Global Outsourcing in Drug Development Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Outsourcing in Drug Development Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Industries Case Studies
 Figure 9. Biotechnology Industries Case Studies
 Figure 10. Medical Device Industries Case Studies
 Figure 11. Outsourcing in Drug Development Report Years Considered
 Figure 12. Global Outsourcing in Drug Development Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Outsourcing in Drug Development Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Outsourcing in Drug Development Market Share by Region: 2024 VS 2031
 Figure 15. Global Outsourcing in Drug Development Market Share by Players in 2024
 Figure 16. Global Top Outsourcing in Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Outsourcing in Drug Development as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Outsourcing in Drug Development Revenue in 2024
 Figure 18. North America Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Outsourcing in Drug Development Market Share by Country (2020-2031)
 Figure 20. United States Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Outsourcing in Drug Development Market Share by Country (2020-2031)
 Figure 24. Germany Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Outsourcing in Drug Development Market Share by Region (2020-2031)
 Figure 32. China Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Outsourcing in Drug Development Market Share by Country (2020-2031)
 Figure 40. Mexico Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Outsourcing in Drug Development Market Share by Country (2020-2031)
 Figure 44. Turkey Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Outsourcing in Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Charles River Laboratories Revenue Growth Rate in Outsourcing in Drug Development Business (2020-2025)
 Figure 48. Covance Revenue Growth Rate in Outsourcing in Drug Development Business (2020-2025)
 Figure 49. ICON Revenue Growth Rate in Outsourcing in Drug Development Business (2020-2025)
 Figure 50. Parexel Revenue Growth Rate in Outsourcing in Drug Development Business (2020-2025)
 Figure 51. Quintiles Transnational Revenue Growth Rate in Outsourcing in Drug Development Business (2020-2025)
 Figure 52. PPD Revenue Growth Rate in Outsourcing in Drug Development Business (2020-2025)
 Figure 53. PRA Health Sciences Revenue Growth Rate in Outsourcing in Drug Development Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS